Correlation Between Halozyme Therapeutics and TG Therapeutics
Can any of the company-specific risk be diversified away by investing in both Halozyme Therapeutics and TG Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Halozyme Therapeutics and TG Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Halozyme Therapeutics and TG Therapeutics, you can compare the effects of market volatilities on Halozyme Therapeutics and TG Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Halozyme Therapeutics with a short position of TG Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Halozyme Therapeutics and TG Therapeutics.
Diversification Opportunities for Halozyme Therapeutics and TG Therapeutics
-0.33 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Halozyme and TGTX is -0.33. Overlapping area represents the amount of risk that can be diversified away by holding Halozyme Therapeutics and TG Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on TG Therapeutics and Halozyme Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Halozyme Therapeutics are associated (or correlated) with TG Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of TG Therapeutics has no effect on the direction of Halozyme Therapeutics i.e., Halozyme Therapeutics and TG Therapeutics go up and down completely randomly.
Pair Corralation between Halozyme Therapeutics and TG Therapeutics
Given the investment horizon of 90 days Halozyme Therapeutics is expected to under-perform the TG Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Halozyme Therapeutics is 1.04 times less risky than TG Therapeutics. The stock trades about -0.02 of its potential returns per unit of risk. The TG Therapeutics is currently generating about 0.32 of returns per unit of risk over similar time horizon. If you would invest 2,435 in TG Therapeutics on August 28, 2024 and sell it today you would earn a total of 1,026 from holding TG Therapeutics or generate 42.14% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Halozyme Therapeutics vs. TG Therapeutics
Performance |
| Timeline |
| Halozyme Therapeutics |
| TG Therapeutics |
Halozyme Therapeutics and TG Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Halozyme Therapeutics and TG Therapeutics
The main advantage of trading using opposite Halozyme Therapeutics and TG Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Halozyme Therapeutics position performs unexpectedly, TG Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in TG Therapeutics will offset losses from the drop in TG Therapeutics' long position.| Halozyme Therapeutics vs. Agios Pharm | Halozyme Therapeutics vs. Insmed Inc | Halozyme Therapeutics vs. Ultragenyx | Halozyme Therapeutics vs. Biomarin Pharmaceutical |
| TG Therapeutics vs. Eliem Therapeutics | TG Therapeutics vs. HCW Biologics | TG Therapeutics vs. Scpharmaceuticals | TG Therapeutics vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Complementary Tools
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Stocks Directory Find actively traded stocks across global markets | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |